Antibody Fragments Market to Witness Steady Growth During the Forecast Period 2016–2024
Whole antibodies have grabbed a significant share of the global sales revenue as well as the volume of the biopharmaceuticals market. But with recent research and development efforts, it has come to light that the whole or full-length antibodies may always not be needed, or sometimes may not be desirable even for therapeutic use. Antibody fragments come in the picture at this point. For example, anti-tumor antibodies are larger in size and therefore can't penetrate the tumor, thus affecting their...
View full press release